2010 Press Releases

Keyword Search

2010 | 2009 | 2008 | 2007

Date Title   08/05/10 Response Genetics, Inc. Reports Second Quarter 2010 Financial Results 07/29/10 Response Genetics, Inc. to Announce Second Quarter 2010 Financial Results 07/15/10 Response Genetics Inc. Sets Date for 2010 Annual Meeting of Stockholders, Announces Board Slate 06/30/10 Response Genetics Launches EML4-ALK Genetic Test in Lung Cancer 06/10/10 Response Genetics, Inc. Announces Appointment of Chief Operating Officer 06/02/10 Response Genetics to Present Lung Cancer and Colorectal Cancer Study Results at the 2010 American Society of Clinical Oncology Annual Meeting 05/13/10 Response Genetics, Inc. Reports First Quarter 2010 Financial Results 05/11/10 Response Genetics, Inc. to Release First Quarter 2010 Financial Results 05/11/10 Response Genetics Signs Agreement with GlaxoSmithKline to Provide Proprietary BRAF Mutational Analysis Technology 05/05/10 Response Genetics, Inc. Appoints Chief Financial Officer 03/31/10 Response Genetics, Inc. Reports Full Year 2009 and Fourth Quarter Financial Results 03/29/10 Response Genetics Announces Resignation of Chief Financial Officer 03/26/10 Response Genetics, Inc. to Release Full Year 2009 and Fourth Quarter Financial Results 03/10/10 Response Genetics Announces Receipt of NASDAQ Non-Compliance Letter upon Resignation of Board Member 03/08/10 Response Genetics Announces $4 Million Private Placement 02/03/10 Response Genetics to Present at the 20th Annual UBS Global Healthcare Services Conference and at the 12th Annual BIO CEO & Investor Conference 01/19/10 Response Genetics Announces Appointment of Dr. Edith P. Mitchell to Board of Directors 01/11/10 Response Genetics to Increase Sales Force by 50 percent to Meet Growing Demand for its ResponseDX(TM) Tests 01/06/10 Response Genetics Inc. Announces Distribution Agreement with Genetic Technologies Ltd. to Expand the Availability of ResponseDX(TM) Molecular Diagnostic Tests Internationally